Epithelial-mesenchymal transition (EMT) and its critical roles during cancer progression have long been recognized and extensively reviewed. Recent studies on the generation of induced pluripotent ...
1 天on MSN
Vimentin is a type III intermediate filament (IF) protein normally expressed in cells that develop into connective tissue, ...
it has been identified as a leading factor promoting epithelial-mesenchymal transition (EMT) of cancer cells and causing cancer metastasis. In this review, we have overviewed the latest findings of ...
Ephrin A1 facilitates colonization and metastasis of gastric cancer cells in vitro and in vivo via inducing epithelial-mesenchymal transition (EMT). Ephrin A1 directly interacts with EGFR and induces ...
A team led by UT Southwestern scientists has discovered a mechanism that promotes metastasis in pancreatic, breast, and potentially other cancers, along with a new druggable therapeutic target to ...
14 小时
AZoLifeSciences on MSNMutant Vimentin Promotes Aggressive Breast Cancer GrowthVimentin is a type III intermediate filament (IF) protein typically expressed in cells that differentiate into connective ...
CIRBP Family, Tumors, Molecular Mechanisms, RNA-Binding Proteins, Cellular Stress Share and Cite: Cai, Y. , Wang, T. and Zhan ...
1 天
News Medical on MSNChanges to intermediate filament protein drives aggressive breast cancer growthChanges to the intermediate filament (IF) protein, vimentin, were found to promote tumor growth by increasing cancer stemness in an oestrogen independent manner.
New research has found that changes to the intermediate filament (IF) protein, vimentin, were found to promote tumor growth.
The program has shown strong ... Outside-in Signaling Shows a Route Into Cancer Cells Feb. 4, 2025 — A new study shows how an anticancer drug triggers an 'outside in' signal that gets it sucked ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果